HomeAbout JournalEditorial BoardSubmission GuidelinesSubscriptionContact UsChinese
Quote : 胡慧钰,刘姝妍,班翊,李欣.CCR5在三阴性乳腺癌组织中的表达及其对5年生存的影响[J].湖南中医药大学学报英文版,2018,38(5):558-561.[Click to copy ]
【Print 】      【Download PDF 】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous |Next→ Archive    Advanced Search
This paper :Browser 5045times   Download 1005times
CCR5在三阴性乳腺癌组织中的表达及其对5年生存的影响
胡慧钰,刘姝妍,班翊,李欣
(中南大学湘雅医院 乳腺科, 湖南 长沙 410008;吉林大学第二医院 妇产科, 吉林 长春 130000;美国康奈尔大学威尔医学院, 纽约 美国 10065)
摘要:
    目的 研究CCR5在三阴性乳腺癌(TNBC)中的表达以及其对患者生存预后的影响。方法 使用免疫组化方法检测CCR5在62例三阴性乳腺癌癌组织标本中的表达水平,绘制Kaplan-Meier曲线分析CCR5表达水平对患者生存预后的影响。结果 在62例临床三阴性乳腺癌癌组织标本中,29例样本CCR5高表达,占样本总数的46.77%;33例样本CCR5低表达,占样本总数的53.22%。5年生存分析:CCR5高表达与三阴性乳腺癌患者5年生存呈负相关(P=0.0031<0.05)。结论 CCR5在中国湖南地区乳腺癌患者癌组织样本中均有表达,高表达CCR5提示患者预后较差,高表达CCR5可能促进三阴性乳腺癌进展及转移。
关键词:  CCR5  CCL5  三阴性乳腺癌  5年生存
DOI:10.3969/j.issn.1674-070X.2018.05.018
Received:April 22, 2018  
基金项目:美国NIH训练项目(T325T32AI007621-15)。
CCR5 Expression in Triple-Negative Breast Cancer Tissue and Its Impact on 5 Year Survival
HU Huiyu,LIU Shuyan,BAN Yi,LI Xin
(Department of Breast Surgery, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China;Department of Obstetrics and Gynecology, the Second Hospital of Jilin University, Changchun, Jilin 130000, China;Weill Cornell Medicine, New York 10065, America)
Abstract:
    Objective To investigate the CCR5 expression in triple-negative breast cancer (TNBC) tissue, and its impact on survival prognosis. Methods The CCR5 expression in 62 specimens of TNBC were determined by immunochemical staining. Kaplan-Meier estimate was used to analyze the survival prognosis of TNBC patients. Results 29 cases, accounted for 46.77%, showed high expression of CCR5, and 33 cases, accounted for 53.22%, showed low expression of CCR5. High expression of CCR5 was negatively correlated with the 5-year-survival rates of these TNBC patients. Conclusion In the triple negative breast cancer patients in Hunan region of China, CCR5 is expressed. The high level expression of CCR5 indicated bad survival prognosis. CCL5/CCR5 may promote TNBC progression and metastasis.
Key words:  CCR5  CCL5  triple negative breast caner  5-year-survival
本文二维码信息
二维码(扫一下试试看!)
Adress:No. 300, Xueshi Road, Hanpu Science and Education Park, Yuelu District, Changsha City, Hunan Province(410208)    Telephone0731-88458947     E-mail:xuebaotcm@126.com
Technical support :Beijing Qinyun Technology Development Co., Ltd